demonstrated that BSA‐stabilized Se nanoparticles (BSA‐SeNPs) can inhibit secondary brain damage caused by ferroptosis after hemorrhagic stroke by activating the Nrf2/GPX4 pathway [81]. The gene discussed is GPX4; the disease is hemorrhagic stroke.